Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 20, Issue 5, 1999, Pages 448-454

  Rompalo, Anne M ^a   Astemborski, Jacquie ^a   Schoenbaum, Ellie ^b   Schuman, Paula ^c   Carpenter, Charles ^d   Holmberg, Scott D ^e   Warren, Dora L ^f   Farzadegan, Homayoon ^a   Vlahov, David ^a   Smith, Dawn K ^f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BROWN UNIVERSITY   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f Johns Hopkins Univ Sch of Medicine ^*

Author keywords

AIDS; Clinical manifestations; HIV; HIV 1 viral load; Risk group; Women

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SEXUAL BEHAVIOR; VIRUS INFECTION; VIRUS LOAD;

DNA VIRUSES; HERPES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033560730     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199904150-00006     Document Type: Article

References (26)

1. Polk BF, Fox R, Brookmeyer R, et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987;316:61-6.
2. Moss AR, Bacchetti P, Osmond D, et al. Seropositivity for HIV and the development of AIDS or AIDS-related condition: three year follow-up of the San Francisco General Hospital cohort. BMJ 1988;296:745-50.
3. Eyster ME, Gail MH, Ballard JO, et al. Natural history of immunodeficiency virus infection in hemophiliacs: effects of T-cell subsets, platelet count and age. Ann Intern Med 1987;107:1-6.
4. Ward JW, Bush TJ, Perkins HA, et al. The natural history of transfusion-associated infection with human immunodeficiency virus: factors influencing the rate of progression to disease. N Engl J Med 1989;321:937-42.
5. Geisecke J, Scalia-Tomba G, Berglund O, Berntorp E, Schulman S, Stigendal L. Incidence of symptoms and AIDS in 146 Swedish hemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. BMJ 1988;297:99-102.
6. Greenspan D, Greenspan JS, Hearst NG, et al. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and risk of developing AIDS. J Infect Dis 1987;155:475-81.
7. Kaslow RA, Phair JP, Friedman HB, et al. Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency - a report from the Multicenter AIDS Cohort Study. Ann Intern Med 1987;107:474-80.
8. Klein RS, Harris CA, Small C, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354-8.
9. Palenicek J, Nelson KE, Vlahov D, Galai N, Cohn S, Saah AJ. Comparison of clinical symptoms of HIV disease between intravenous drug users and homosexual men. Arch Intern Med 1993; 153:1806-12.
10. Farizo KM, Buehler JW, Chamberland ME, et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992;267:1798-1805.
11. Greenberg NE, Thomas PA, Landesman SH, et al. The spectrum of HIV-1 related disease among outpatients in New York City. AIDS 1992;6:849-59.
12. Vlahov D, Muñoz A, Solomon L, et al. Comparison of clinical manifestations of HIV infection between male and female injecting drug users. AIDS 1994;8:819-23.
13. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54.
14. + cell count. JAMA 1998;279(1):35-40.
15. Centers for Disease Control and Prevention. 1995 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1995;44[RR-8]:1-35.
16. Carpenter CCJ, Fischl MA, Hammer SM, et al., for the International AIDS Society - USA. Antiretroviral therapy for HIV infection in 1996: recommendations of an international panel. JAMA 1996;276:146-54.
17. Carpenter CCJ, Fischl MA, Hammer SM, et al., for the International AIDS Society - USA. Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society - USA Panel. JAMA 1997;24:1962-9.
18. Farzadegan H, Hoover DR, Astemborski J, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998;352:1510-14.
19. Smith DK, Warren DL, Vlahov D, et al., for the HER Study Group. Design and baseline participant characteristics of the human immunodeficiency virus epidemiology research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 1997;146:459-69.
20. Hoffman RA, Kunge PC, Hansen WP, et al. Simple and rapid measurement of human T-lymphocytes and their subclasses in peripheral blood. Proc Natl Acad Sci USA 1980;77:4914-17.
21. Giorgi JV, Cheng HL, Margolick JB, et al. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the Multicenter AIDS Cohort experience. Clin Immunol Immunopathol 1990;55:173-86.
22. Rosner B. Fundamentals of biostatistics. Boston: Duxbury Press, 1982.
23. Sulkowski MS, Chaisson RE, Karp CL, Moore RD, Margolick JB, Quinn TC. The effect of acute infectious illness on plasma HIV-1 viral load and the expression of serological markers of immune activation among HIV-infected adults. J Infect Dis 1998 (in press).
24. Katzenstein DA, Hammer SM, Hughes MD, et al. The relation of virologie and immunologic markers to clinical outcomes after nucleoside analogue therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virologie Study. N Engl J Med 1996;335:1091-8.
25. Evans JS, Nims T, Cooley J, et al. Serum levels of virus burden in early-stage human immunodeficiency virus type 1 disease in women. J Infect Dis 1997;175:795-800.
26. Sterling TR, Lyles CM, Vlahov D, Astemorski J, Quinn TC. Gender-specific differences in plasma HIV-1 RNA levels among HIV-1 seroconverters followed longitudinally [abstract #13379]. XII World Conference on AIDS, Geneva, Switzerland, 1998.